NCT03473691 2024-12-09
Breast50
University of Virginia
Phase EARLY_PHASE1 Withdrawn
Clinical Trials
5 trialsNCT01997333 2019-03-08
METRIC
Celldex Therapeutics
Phase 2 Completed
NCT03326258 2018-07-18
Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 1/2 Withdrawn
NCT03067935 2018-05-21
Individual Patient Expanded Access-Glembatumumab Vedotin
Celldex Therapeutics
No longer available
NCT01156753 2017-07-02
EMERGE
Celldex Therapeutics
Phase 2 Completed